BX Swiss TOP 30 CHF
1.218,09
PKT
-9,95
PKT
-0,81
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
26.07.21 | UBS Equal-weight | Morgan Stanley | |
26.07.21 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
26.07.21 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.07.21 | Roche Neutral | Credit Suisse Group | |
23.07.21 | Givaudan Buy | UBS AG | |
23.07.21 | Novartis Buy | UBS AG | |
23.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
23.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
23.07.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
23.07.21 | Givaudan Add | Baader Bank | |
23.07.21 | UBS Sector Perform | RBC Capital Markets | |
23.07.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
22.07.21 | Novartis Hold | Deutsche Bank AG | |
22.07.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.21 | Roche Neutral | UBS AG | |
22.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
22.07.21 | Novartis Neutral | Credit Suisse Group | |
22.07.21 | Givaudan Add | Baader Bank | |
22.07.21 | Roche Buy | Jefferies & Company Inc. | |
22.07.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
22.07.21 | Givaudan Underperform | Bernstein Research | |
22.07.21 | Roche Outperform | Bernstein Research | |
22.07.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
22.07.21 | Givaudan Underperform | Jefferies & Company Inc. | |
22.07.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
22.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
22.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Market-Perform | Bernstein Research | |
21.07.21 | Holcim Buy | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Market-Perform | Bernstein Research | |
21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
21.07.21 | UBS Outperform | Credit Suisse Group | |
21.07.21 | UBS Underweight | Barclays Capital | |
21.07.21 | Zurich Insurance Overweight | Morgan Stanley | |
21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Buy | UBS AG | |
21.07.21 | Novartis Buy | Jefferies & Company Inc. |